Annual report [Section 13 and 15(d), not S-K Item 405]

ACCRUED EXPENSES

v3.25.0.1
ACCRUED EXPENSES
 12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
ACCRUED EXPENSES
10.
ACCRUED EXPENSES

Accrued expenses consisted of the following (in thousands):

 

 

 

December 31,
2024

 

 

December 31,
2023

 

 

 

 

 

 

 

 

Accrued pre-clinical and clinical costs

 

$

2,424

 

 

$

1,449

 

Accrued product development costs

 

 

280

 

 

 

745

 

Accrued license costs

 

 

—

 

 

 

4,825

 

Accrued compensation

 

 

2,276

 

 

 

2,326

 

Accrued administrative costs

 

 

446

 

 

 

343

 

Accrued interest

 

 

—

 

 

 

1,342

 

Total

 

$

5,426

 

 

$

11,030